Walgreens Boots Alliance Aktie
WKN DE: A12HJF / ISIN: US9314271084
19.04.2021 15:38:36
|
Walgreens, Abbott Agree To Sell BinaxNOW Antigen Self Test Through Walgreens Stores
(RTTNews) - Walgreens has entered into an agreement with Abbott to sell the BinaxNOW Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide. The test will be available nationwide for $23.99.
On March 31, 2021, Abbott received FDA Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW COVID-19 Self Test for detection of COVID-19 infection. The new indication allows individuals with or without symptoms to have access to this test without a prescription.
Walgreens said, by May, it will expand testing to 6,000 drive-thru testing sites with half of these sites offering the no-cost, rapid Abbott ID NOW COVID-19 test.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walgreens Boots Alliance Incmehr Nachrichten
Analysen zu Walgreens Boots Alliance Incmehr Analysen
04.01.24 | Walgreens Boots Alliance Neutral | UBS AG |
Aktien in diesem Artikel
Abbott Laboratories | 113,96 | 0,11% |
|
Walgreens Boots Alliance Inc | 9,70 | 0,46% |
|